199 results
8-K
EX-10.2
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
9 Sep 11
Entry into a Material Definitive Agreement
12:00am
damage to property and injury to persons while on the Property under this license. Licensee waives any claim it may have against Licensor arising out … Licensor from any claim of damage to property or injury to person arising from Licensee’s use of this license or the Licensed Premises or a breach
8-K
EX-10.2
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
4 Aug 06
Ligand Announces that David Robinson Steps Down as Chairman, President and CEO; Henry Blissenbach Named Chairman and Interim CEO
12:00am
, personal injury, invasion of privacy, violation of public policy, negligence and/or any other common law, statutory or other claim whatsoever arising out
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
2 Apr 02
Other events
12:00am
. AVINZA is a controlled substance and
therefore has a number of special regulatory restrictions. It also may be abused
or misused, causing injury or death
8-K
EX-99.1
2ksgp znzlwkn4uag1s
19 Nov 12
Other Events
12:00am
8-K
EX-99.1
gmlacsqwx1 n4gymur
20 Oct 20
Results of Operations and Financial Condition
10:52am
S-4
EX-10.7
o2c2 r811e7
9 Jul 98
Registration of securities issued in business combination transactions
12:00am
10-K/A
EX-10.169
pp9l0dun158gzs8r5
25 Nov 98
Annual report (amended)
12:00am
8-K
EX-99.1
87mx0vil5v6
12 Mar 19
Regulation FD Disclosure
10:02am
S-3/A
uv2y32znl
22 Oct 96
Shelf registration (amended)
12:00am
S-8
7ndvl9nbbr 92
29 Jul 97
Registration of securities for employees
12:00am
8-K
EX-10.1
gibx9ed26gbbg64 m8s
31 Oct 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
vlktv
9 Sep 11
Entry into a Material Definitive Agreement
12:00am